Sponsor Pipeline

Avenzo Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
4
Recruiting
6
Disease Areas
Active Trials by Phase
Phase 1/2
4
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT05867251 Study of AVZO-021 in Patients With Advanced Solid Tumors Advanced Solid Tumor Recruiting
NCT07038343 AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients… Solid Tumor Cancer Recruiting
NCT07193511 BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With… Solid Tumor Cancer Recruiting
NCT06998407 ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or… HR+/HER2- Breast Cancer Recruiting
Disease Areas
Breast Cancer (2) Triple-Negative Breast Cancer (1) Ovarian Cancer (1) Endometrial Cancer (1) Lung Cancer (1) Cholangiocarcinoma (1)
Get alerts when Avenzo Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free